WoundReference improves clinical decisions
 Choose the role that best describes you
Guo J, Dardik A, Fang K, Huang R, Gu Y, et al.
Stem cell research & therapy. Date of publication 2017 Oct 16;volume 8(1):228.
1. Stem Cell Res Ther. 2017 Oct 16;8(1):228. doi: 10.1186/s13287-017-0683-2. Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells. Guo J(1)(2), Dardik A(3), Fang K(4), Huang R(5), Gu Y(6)(7). Author information: (1)Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. (2)Institute of Vascular Surgery, Capital Medical University, Beijing, China. (3)Section of Vascular Surgery, Vascular Biology and Therapeutics, Yale University, New Haven, CT, USA. (4)Yale University, New Haven, CT, USA. (5)Occupational and Environmental Health, Xiangya School of Public Health, Central South University, Hunan, China. huangruixue@csu.edu.cn. (6)Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. gu15901598209@gmail.com. (7)Institute of Vascular Surgery, Capital Medical University, Beijing, China. gu15901598209@gmail.com. Over the last decade, many studies have indicated a therapeutic potential for treating diabetic lower extremity ulcers with autologous stem cells. The aim of the current study was to conduct a systematic review and meta-analysis of the treatment of diabetic foot ulcers (DFUs) with autologous stem cells. The search strategy included the Pubmed, EMBASE, Web of Science, and Cochrane's Library databases. The endpoint measured was the healing of DFUs.Six eligible randomized controlled trial (RCT) studies were screened from related published studies and reviewed for meta-analysis. The overall meta-analysis showed that stem cell administration was significantly favorable for healing diabetic ulcers (mean difference (MD) 0.52, 95% confidence interval (CI) 0.38-0.65; p < 0.00001). Subgroup analyses indicated that stem cells seemed to exert similar beneficial effects on patients with ulcer size ≥ 5 cm2 (MD 0.76, 95% CI 0.55-0.97; p < 0.00001) and < 5 cm2 (MD 0.43, 95% CI 0.31-0.54; p < 0.00001). Furthermore, stem cells had similar effects on patients aged ≥ 70 years (MD 0.61, 95% CI 0.14-1.08; p = 0.01) and < 70 years (MD 0.47, 95% CI 0.35-0.58; p < 0.00001). This systematic review and meta-analysis suggests a promising role for stem cells in DFU treatment. This review will pave the way to further study on the long-term effects of stem cell-based therapy and large-scale RCTs. DOI: 10.1186/s13287-017-0683-2 PMCID: PMC5644171 PMID: 29037219 [Indexed for MEDLINE]
Appears in following Topics:
Diabetic Foot Ulcer - Treatment